临床药师对某院丙氨酰谷氨酰胺注射液应用干预分析

doi:10.19803/j.1672-8629.20230668

中国药物警戒 ›› 2024, Vol. 21 ›› Issue (2): 181-184.
DOI: 10.19803/j.1672-8629.20230668

临床药师对某院丙氨酰谷氨酰胺注射液应用干预分析

范凯凯¹, 王聪¹, 刘洪峰¹, 王西勇^2,*

¹安徽医科大学附属宿州医院药学部,安徽宿州 234000;
²安徽医科大学附属宿州医院肿瘤科,安徽宿州 234000

收稿日期:2023-05-22 出版日期:2024-02-15 发布日期:2024-02-06
通讯作者: ^*王西勇,男,博士,副主任医师,肺癌机制研究。E-mail: wangxiyong@ahmu.edu.cn.
作者简介:范凯凯,男,本科,主管药师,肠外肠内营养临床医学。
基金资助:
安徽省卫生健康委科研项目（AHWJ2021a040）

Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital

FAN Kaikai¹, WANG Cong¹, LIU Hongfeng¹, WANG Xiyong^2,*

¹Department of Pharmacy, Suzhou Hospital of Anhui Medical University, Suzhou Anhui 234000, China;
²Department of Oncology, Suzhou Hospital of Anhui Medical University, Suzhou Anhui 234000, China

Received:2023-05-22 Online:2024-02-15 Published:2024-02-06

摘要/Abstract

摘要： 目的探讨临床药师干预对降低某院丙氨酰谷氨酰胺注射液应用不合理率的成效性。方法采取单纯随机抽样方式抽取医院2021年6月1日至8月31日（干预前）和2022年6月1日至8月31日（干预后）应用丙氨酰谷氨酰胺注射液的医嘱各200份,针对相应的问题进行对比分析。结果干预后应用丙氨酰谷氨酰胺注射液的不合理率明显降低,由干预前的77.50%降至41.00%（P<0.05）,其有统计学意义。结论临床药师采取干预措施后,对降低不合理用药率有促进作用,但仍需持续跟踪和改进。

关键词: 丙氨酰谷氨酰胺, 药学干预, 临床药师, 应用, 效果分析, 医嘱, 不合理用药

Abstract: Objective To investigate the effectiveness of interventions by clinical pharmacists for reducing the irrational rate of alanyl-glutamine injections in a hospital. Methods A simple random sampling method was adopted to select 200 medical orders related to alanyl-glutamine injections that were given by clinicians between June and August 2021 (before interventions) and another 200 between June and August 2022 (after interventions) before the corresponding problems were compared and analyzed. Results The irrational rate of alanyl-glutamine injections decreased from 77.50% to 41.00% after interventions (P<0.05), which was of statistical significance. Conclusion The interventions enforced by clinical pharmacists can help make drug use more rational, but continued tracking and improvement are needed.

Key words: alanyl-glutamine, pharmacists’ intervention, clinical pharmacist, application, effect analysis, medical orders, irrational drug use

中图分类号:

范凯凯, 王聪, 刘洪峰, 王西勇. 临床药师对某院丙氨酰谷氨酰胺注射液应用干预分析[J]. 中国药物警戒, 2024, 21(2): 181-184.

FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://www.zgywjj.com/CN/10.19803/j.1672-8629.20230668

https://www.zgywjj.com/CN/Y2024/V21/I2/181

参考文献

[1] DURANTE W.Glutamine deficiency promotes immune and endothelial cell dysfunction in COVID-19[J]. Int J Mol Sci, 2023, 24(8): 7593.
[2] HU J, ZHENG Y, YING H, et al.Alanyl-glutamine protects mice against methionine-and choline-deficient-diet-induced steatohepatitis and fibrosis by modulating oxidativestress and inflammation[J]. Nutrients, 2022, 14(18): 3796.
[3] MOORE SR, QUINN LA, MAIER EA, et al.Intervention and mechanisms of alanyl-glutamine for inflammation, nutrition, and enteropathy: a randomized controlled trial[J]. J Pediatr Gastroenterol Nutr, 2020, 71(3): 393-400.
[4] ZHU MW, YANG H, CHEN W, et al.Expert consensus on clinical application of intravenous alanyl-glutamine dipeptide[J]. Chinese Journal of Clinical Nutrition(中华临床营养杂志), 2021, 29(4): 196-197.
[5] Chinese Society for Parenteral and Enteral Nutrition. Guideline for clinical application of parenteral and enteral nutrition in adults patients in China (2023 edition)[J]. National Medical Journal of China(中华医学杂志), 2023, 103(13): 960-961.
[6] SUN YJ, ZHU SZ, AN JF, et al.Rationality of parenteral nutrition prescriptions by department of general surgery of a hospital in 2019-2021[J]. Pharmaceutical Journal of Chinese People’s Liberation Army(解放军药学学报), 2023, 36(1): 46-48.
[7] Chinese Society for Parenteral and Enteral Nutrition. Nutritional risk screening and GLIM steps 2 and 3 for the diagnosis of malnutrition and severity of malnutrition(Consensus 2020)[J]. Chinese Journal of Clinical Nutrition(中华临床营养杂志), 2020, 28(4): 193-200.
[8] MATSUI R, SAGAWA M, SANO A, et al.Impact of perioperative immunonutrition on postoperative outcomes for patients undergoing head and neck or gastrointestinal cancer surgeries: a systematic review and meta-analysis of randomized controlled trials[J]. Ann Surg, 2023, 278(6): 873-882.
[9] COMPHER C, BINGHAM AL, MCCALL M, et al.Guidelines for the provision of nutrition support therapy in the adult critically ill patient: the american society for parenteral and enteral Nutrition[J]. JPEN J Parenter Enteral Nutr, 2022, 46(1): 12-41.
[10] WEIANN A, BRAGA M, CARLI F, et al.ESPEN practical guideline: clinical nutrition in surgery[J]. Clin Nutr, 2021, 40(7): 4748-4749.
[11] WU JM, HO TW, LAI IR, et al.Parenteral glutamine supplementation improves serum albumin values in surgical cancer patients[J]. Clin Nutr, 2021, 40(2): 647-649.
[12] YANG YQ, CHEN B, ZHANG XM, et al.Effect analysis of continuous interventions by clinical pharmacists on the rational use of alanyl glutamine[J]. Anhui Medical and Pharmaceutical Journal(安徽医药), 2019, 23(3): 628-631.
[13] HOLECEK M.Side effects of long-term glutamine supplementation[J]. JPEN J Parenter Enteral Nutr, 2013, 37(5): 609-613.
[14] BARTOSOVA M, HERZOG R, RIDINGER D, et al.Alanyl-glutamine restores tight junction organization after disruption by a conventional peritoneal dialysis fluid[J]. Biomolecules, 2020, 10(8): 1178.
[15] Chinese Society for Parenteral and Enteral Nutrition. Chinese expert consensus on clinical use of multi-trace elements injection(2021)[J]. Electron J Metab Nutr Cancer(肿瘤代谢与营养电子杂志), 2021, 8(4): 368-369.
[16] HU YY, JIA Y, CHEN AN, et al.Clinical pharmacist intervention in the use of alanyl glutamine injection to improve adverse reactions and irrational medication[J]. Medical Innovation of China(中国医学创新), 2021, 18(15): 172-176.
[17] THOMAS K, ZONDLER L, LUDWIG N, et al.Glutamine prevents acute kidney injury by modulating oxidative stress and apoptosis in tubular epithelial cells[J]. JCI Insight, 2022, 7(21): e163161.
[18] FRIEG B, GÖRG B, GOHLKE H, et al. Glutamine synthetase as a central element in hepatic glutamine and ammonia metabolism: novel aspects[J]. Biol Chem, 2021, 402(9): 1063-1072.
[19] CRUZAT V, MACEDO RM, NOEL KK, et al.Glutamine: metabolism and immune function, supplementation and clinical translation[J]. Nutrients, 2018, 10(11): 1564.
[20] BELANGER AJ, GEFTEAS E, PRZYBYLSKA M, et al.Excretion of excess nitrogen and increased survival by loss of SLC6A19 in a mouse model of ornithine transcarbamylase deficiency[J]. J Inherit Metab Dis, 2023, 46(1): 55-65.
[21] LIN H, QIN Z, DAI GY, et al.Parenteral nutrition prescription in a hospital[J]. China Pharmaceuticals(中国药业), 2022, 31(7): 112-116.
[22] SONG XM, SHENG XL, PENG J.Comprehensive review of doctor's orders of total parenteral nutrition in our hospital[J]. Pharmaceutical and Clinical Research(药学与临床研究), 2020, 28(1): 56-59.
[23] LI BY, ZHANG ZC.Study on compatibility stability of combined alanyl glutamine injection[J]. Strait Pharmaceutical Journal(海峡药学), 2020, 32(4): 24-26.
[24] LIANG H, YANG M, WU W, et al.Establishment and application of rational evaluation criteria for alanyl glutamine[J]. Chinese Journal of New Drugs and Clinical Remedies(中国新药与临床杂志), 2020, 39(10): 633.
[25] SUHOYO Y, SCHÖNROCK-ADEMA J, EMILIA O, et al. How students and specialists appreciate the mini-clinical evaluation exercise (mini-CEX) in Indonesian clerkships[J]. BMC Med Educ. 2020, 20(1): 144.

临床药师对某院丙氨酰谷氨酰胺注射液应用干预分析

Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	黎海燕, 杨忠旭, 刘跃昆, 王丽虹. 1例甲氨蝶呤治疗异位妊娠致严重不良反应患者的药学监护[J]. 中国药物警戒, 2024, 21(4): 454-456.
[2]	刘琦, 张玉凤, 罗皓, 李歆. 106例安罗替尼临床应用的合理性与安全性分析[J]. 中国药物警戒, 2024, 21(3): 329-334.
[3]	地力乎马·地力木拉提, 石伟, 王伽伯, 高源. 基于毒/效记载演变探讨补骨脂的安全应用研究进展[J]. 中国药物警戒, 2023, 20(8): 939-945.
[4]	李亚梅, 水荣. 托法替尼治疗幼年特发性关节炎研究进展[J]. 中国药物警戒, 2023, 20(8): 956-960.
[5]	陈婕, 秦侃. 肠外营养个体化给药实践评价[J]. 中国药物警戒, 2023, 20(7): 812-816.
[6]	刘婧, 夏亮, 张世杰. 1例多元药物过敏急性胰腺炎患者行药物激发试验的药学监护[J]. 中国药物警戒, 2023, 20(7): 822-824.
[7]	殷进军, 王淑伟, 邵姜超, 王冰. 基于加权TOPSIS法的贝伐珠单抗注射液药物利用评价[J]. 中国药物警戒, 2023, 20(12): 1421-1426.
[8]	苏甦, 伍诗琪, 张青霞, 闫素英. 1例吲达帕胺致粒细胞缺乏症患者的药学监护[J]. 中国药物警戒, 2023, 20(11): 1282-1285.
[9]	卫红涛, 沈素, 李丹丹, 廖音. 705例神经内科问题医嘱的帕累托图分析[J]. 中国药物警戒, 2022, 19(8): 900-903.
[10]	原小陇, 万齐华, 陶东红, 祁浩, 王爱霞. 1例甲氨蝶呤片严重中毒患者的药学监护[J]. 中国药物警戒, 2022, 19(8): 924-928.
[11]	孙雪林, 张攀, 胡欣. 1例维得利珠单抗治疗重症溃疡性结肠炎的药学监护[J]. 中国药物警戒, 2022, 19(7): 782-785.
[12]	唐静雅. 临床药师参与1例肠外营养相关性肝损伤治疗的药学监护[J]. 中国药物警戒, 2022, 19(7): 786-788.
[13]	杨宝春, 孙欣, 杨欣, 吴琳, 王丽萍. 临床药师参与1例尿路感染伴药物热患者药学实践[J]. 中国药物警戒, 2022, 19(5): 572-573.
[14]	陈方方, 张红旭. 大剂量甲氨蝶呤治疗原发性中枢神经系统淋巴瘤的药学实践[J]. 中国药物警戒, 2022, 19(4): 446-449.
[15]	李友佳, 谢姣, 姚红伊, 计成. 1例甲状旁腺功能减退性心肌病患者的药学监护[J]. 中国药物警戒, 2022, 19(11): 1254-1257.